Chemomab
CMMB
Chemomab (CMMB) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.02
- EPS estimate
- −$0.04
- EPS surprise
- +60.00%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 21, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 21, 2025 | −$0.04 | −$0.02 | +60.00% | $0.00 | SEC |
| Q2 2025 | Aug 14, 2025 | −$0.04 | −$0.02 | +60.00% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.04 | −$0.03 | +30.00% | $0.00 | SEC |
| Q4 2024 | Mar 3, 2025 | −$0.04 | −$0.03 | +20.00% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.04 | −$0.04 | +0.00% | $0.00 | SEC |
| Q2 2024 | Aug 21, 2024 | −$0.04 | −$0.05 | −30.00% | $0.00 | SEC |
| Q1 2024 | May 9, 2024 | −$0.04 | −$0.06 | −40.00% | $0.00 | SEC |
| Q4 2023 | Mar 7, 2024 | −$0.08 | −$0.05 | +35.00% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.12 | −$0.07 | +43.33% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$0.16 | −$0.14 | +10.00% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.14 | −$0.16 | −14.29% | $0.00 | SEC |
| Q2 2022 | Aug 12, 2022 | −$0.72 | −$0.11 | +85.00% | $0.00 | SEC |
| Q1 2022 | May 12, 2022 | −$0.68 | −$0.09 | +87.06% | $0.00 | SEC |
| Q4 2021 | Mar 9, 2022 | −$0.41 | −$0.09 | +78.71% | $0.00 | SEC |
| Q3 2021 | Nov 12, 2021 | −$0.06 | −$0.05 | +13.33% | $0.00 | SEC |
| Q2 2021 | Aug 13, 2021 | −$1.06 | −$0.05 | +95.09% | $0.00 | SEC |
| Q1 2021 | May 13, 2021 | −$0.64 | −$0.04 | +93.75% | $0.00 | — |
| Q2 2020 | Aug 14, 2020 | −$7.04 | −$5.76 | +18.18% | $0.00 | — |
| Q1 2020 | May 7, 2020 | −$7.04 | −$6.40 | +9.09% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Chemomab (CMMB) last report earnings?
Chemomab last reported on Nov 21, 2025, covering fiscal Q3 2025.
Did CMMB beat earnings estimates?
Yes. Chemomab reported EPS of −$0.02 for Q3 2025 against a −$0.04 estimate — a 60.00% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.